immune globulin intravenous, human - dira · Solution

What changed in the last 90 days

Every detected change for immune globulin intravenous, human - dira, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Human Immunoglobulin G, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• human botulinum neurotoxin a/b immune globulin· 1 maker
• human cytomegalovirus immune globulin· 1 maker
• immune globulin infusion (human)· 1 maker
• immune globulin intravenous (human) 10%· 1 maker
• immune globulin subcutaneous (human)· 1 maker
• immune globulin subcutaneous, human-klhw· 1 maker
• rho(d) immune globulin (human)· 1 maker
• vaccinia immune globulin intravenous (human)· 1 maker
• immune globulin· 2 makers
• immune globulin (human)· 2 makers
• immunoglobulin g· 2 makers
• human rho(d) immune globulin· 3 makers

Common questions

Is Immune globulin intravenous, human - dira in shortage right now?

No. FDA does not currently list Immune globulin intravenous, human - dira in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Immune globulin intravenous, human - dira?

2 companies have marketed Immune globulin intravenous, human - dira in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.